Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-11 Sale | 2026-03-13 8:55 pm | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 63,103 | $13.17 | $831,067 | 272,751 (Direct) | View |
| 2025-12-04 Sale | 2025-12-08 8:00 pm | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 12,604 | $16.85 | $212,377 | 484,269 (Direct) | View |
| 2025-11-20 Sale | 2025-11-24 9:39 pm | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 606,402 | $16.73 | $10,144,026 | 633,843 (Direct) | View |
| 2025-03-05 Sale | 2025-03-06 7:21 pm | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 44,665 | $6.9807 | $311,792 | 557,750 (Direct) | View |
| 2024-03-05 Sale | 2024-03-06 7:42 pm | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 29,390 | $3.4363 | $100,994 | 526,964 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 8:02 pm | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 11,749 | $8.57 | $100,689 | 423,375 (Direct) | View |
| 2022-03-07 Sale | 2022-03-08 9:01 pm | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Business Development Off | 2,670 | $12.01 | $32,067 | 308,527 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-04 Option Award | 2026-03-06 7:28 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 39,063 | $0 | 335,854 (Direct) | View |
| 2025-12-04 Exercise | 2025-12-08 8:00 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 4,290 | $12.14 | 484,269 (Direct) | View |
| 2025-12-04 Exercise | 2025-12-08 8:00 pm | N/A 2032-03-04 | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 12,604 | $0 | 484,269 (Direct) | View |
| 2025-12-04 Exercise | 2025-12-08 8:00 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 4,157 | $3.99 | 484,269 (Direct) | View |
| 2025-12-04 Exercise | 2025-12-08 8:00 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 4,157 | $8.46 | 484,269 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 9:39 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 34,375 | $7.27 | 633,843 (Direct) | View |
| 2025-11-20 Exercise | 2025-11-24 9:39 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 188,770 | $12.14 | 633,843 (Direct) | View |
| 2025-11-20 Exercise | 2025-11-24 9:39 pm | N/A 2033-03-06 | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 510,470 | $0 | 633,843 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 9:39 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 70,314 | $6.55 | 633,843 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 9:39 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 83,145 | $3.99 | 633,843 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-24 9:39 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 834 | $6.27 | 633,843 (Direct) | View |
| 2025-11-20 Exercise | 2025-11-24 9:39 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 133,032 | $8.46 | 633,843 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 7:21 pm | N/A 2035-03-04 | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 275,000 | $0 | 557,750 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 7:42 pm | N/A 2034-03-04 | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 332,528 | $0 | 526,964 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:02 pm | N/A 2033-03-06 | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Commercial Ofc Imm Med | 332,528 | $0 | 423,375 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 9:01 pm | N/A 2032-03-04 | Adaptive Biotechnologies Corp | ADPT | BENZENO SHARON Chief Business Development Off | 288,303 | $0 | 308,527 (Direct) | View |